Posts
- The Team Approach
- Staying Knowledgeable About FDA Changes
- A Fight We’re Eager to Engage In
- Outside Focus & Inner Wellness
- Event: FDA Regulatory Strategies and CMC Considerations
- How New Drugs Are Made
- Taking a breather with our new Be Healthy Club
- Proprietary Liposomal Formulation Platform Technology Partnership Opportunity
- China’s CROs Make Connection in S.D.
- Getting Children What They Deserve
- Build me a house - No power tools needed?!
- Meeting: Dispelling the Mystique of Pre-IND Meetings
- The Future Of Drug Development in China
- IRISYS receives Exceptional rating as contractor from NCI
- The Yakatan Rules for Pharma R&D Efficiency #1
- Z-Endoxifen manufactured for the National Cancer Institute
- The Yakatan Rules for Pharma R&D Efficiency #2
- San Diego Food Bank Initiative – Food 4 Kids Backpack Program
- Poor solubility and rapid degradation in acidic environments
- Are you new to the concept of Current Good Manufacturing Practices (cGMPs)?
Pages
Press Releases
- IRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million
- IRISYS Expands Management Team, Appoints Hwa-Chang (Lawrence) Wang Director of Manufacturing
- IRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference
- IRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder
- IRISYS To Expand Drug Delivery Technology Capabilities & Services in China
- IRISYS Chairman, CEO & Founder Represents Biotech Industry at San Diego US-China Trade Relations Meeting
- IRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference
- IRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference
- IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme
- IRISYS Exhibits at Inaugural CPhI North America Conference
- IRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value
- IRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.
- IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum
- IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development
- IRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials
- IRISYS Receives MetroConnect Award & California Competes Tax Credit